Application no. and date | 08018057.3 (espacenet) (Federated) (European Patent Register), 20020911 | Patent/reg. no. and date | DK/EP 2011862, 20110608 | Publication date | 20090107 | Priority no. and date | DE 10144906, 20010912 | EP pub. no. and date |
EP 2011862 20090107 | Effective date | | Applicant/owner | Novartis AG, Lichtstrasse 35 CH-4056 Basel, CH | Applicant ref. no. | P47840DK02 | Inventor | VORLOP, Jürgen, Zum Pfaffengrund 1c
35041 Marburg, DE, LÜBBEN, Holger, An der Koppe 18
35083 Wetter, DE, GREGERSEN, Jens-Peter, Gebr.-Plitt-Str. 25
35083 Wetter, DE, FRECH, Christian, Herbststr. 23
68219 Mannheim, DE | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | C12N 5/07 (2010.01) , C12N 7/00 (2006.01) | Title | Fremgangsmåde til fremstilling af en aktiv bestanddel af et medicinsk- eller diagnosemiddel i MDCK-celledyrkningssuspension | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|